Kristina Hool

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Amgen (United States)(Current)

University of Ulsan

University of Leicester

Antwerp University Hospital

Queen Elizabeth Hospital

Kristina Hool is an author at Amgen (United States) specializing in tumor mutational profiling, circulating tumor dna analysis, and treatment-emergent mutations.

Publications per year

2018–2018

Publications

Impact of Emergent Circulating Tumor DNA <i>RAS</i> Mutation in Panitumumab-Treated Chemoresistant Metastatic Colorectal Cancer

Tae Won Kim, Marc Peeters, Anne Thomas et al. · Clinical Cancer Research · 2018 · 53 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT Study

Marc Peeters, Timothy Price, Michael Boedigheimer et al. · Clinical Cancer Research · 2018 · 39 citations · Full text

Medicine, Molecular Genetics, Oncology +17

1–2 of 2